Camlin Fine Sciences share news, announcements and annual reports
NSE: CAMLINFINEBSE: 532834Chemicals & PetrochemicalsSmall Cap
Camlin Fine Sciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2007 on BSE, Jan 2015 on NSE
Last close ₹84.10up ₹1.78 (2.16%)BSE ₹84.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹82.32.
30 Oct: open ₹82.32, high ₹86.09, low ₹81.00
52-week range of traded prices to 30 Oct 2026
₹78.80Low, 23 Oct 2026₹202.45High, 30 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and fund raising. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,616 Cr1,056th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 274.66
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.67
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,54,30540.5% delivered
Camlin Fine Sciences disputes and clarifications
35 filed, newest first.
Oct 2026
30 Oct · Legal
Apr 2026
10 Apr · Legal
Mar 2026
31 Mar · Legal
16 Mar · Legal
Jan 2026
8 Jan · Legal
The exchange asked on 7 Jan 2026
Dec 2025
31 Dec · Legal
Sep 2025
Jun 2025
23 Jun · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited.
May 2025
2 May · Legal
Feb 2025
5 Feb · Legal
1 Feb · Legal
1 Feb · Legal
Jan 2025
14 Jan · Legal
Jun 2021
1 Jun · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 28-May-2021, regarding Board meeting held on May 28, 2021. On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)2. Brief details of options granted3. Whether the scheme is in terms of SEBI (SBEB) Regulations, 2014 (if applicable);4. Pricing formula;The response of the Company is awaited.
Apr 2021
28 Apr · Legal
The exchange asked on 27 Apr 2021
Feb 2021
16 Feb · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 10-Feb-2021, regarding Notice received from Maharashtra Pollution Control Board. On basis of above the Company is required to clarify following: 1. Expected financial implications, if any, due to compensation, penalty etc; 2. Quantum of claims, if any 3. Brief details of litigation viz. name(s) of the opposing party, court/ tribunal/agency where litigation is filed, brief details of dispute/litigation; The response of the Company is awaited.
Feb 2020
10 Feb · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 08-Feb-2020, regarding Appointment of Internal Auditor. On basis of above the Company is required to clarify following: 1. Date of appointment & term of appointment, 2. Brief profile of the Internal Auditor. The response of the Company is awaited.
Jan 2020
17 Jan · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 16-Jan-2020, regarding closure of the Company's manufacturing unit situated at Plot D- 2/3, MIDC, Tarapur, District Palghar, on account of certain alleged irregularities by the Company in complying with MPCB's terms and conditionsOn basis of above the Company is required to clarify following:1. Brief details of alleged irregularities;2. Expected financial implications, if any, due to compensation, penalty, closure etc;3. Quantum of claims, if anyThe response of the Company is awaited.2 Jan · Legal
The exchange asked on 31 Dec 2019
Oct 2019
25 Oct · Legal
The exchange asked on 24 Oct 2019
Jun 2019
May 2019
30 May · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
Dec 2018
26 Dec · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 24-Dec-2018, regarding "This is to inform you that a minor fire broke out in our factory situated Plot D- 2/3, MIDC, Tarapur, District Palghar, Maharashtra today morning around 7:15 A.M. The fire was brought under control within half hour of the incident. None of the Workmen or other persons was injured or other casualty due to the fire accident.Though the production in factory was temporary disrupted due to the incident, there has been no loss of production. The loss due to fire is negligible and the production at the factory has been resumed. We have already intimated the concerned departments and other statutory authorities about the fire accident.". On basis of above the Company is required to clarify following: 1. Factory/unit where the strike/lock out takes place including reasons for such strike. 2. Estimated impact on the production/operations in case of strikes/lock outs; 3. Whether loss/damage covered by insurance or not including amount; 4. Expected quantum of loss/damage caused; The response of the Company is awaited.
Jun 2018
May 2018
29 May · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 24-May-2018, regarding regarding Board meeting held on May 24, 2018.". On basis of above the Company is required to clarify following: 1. Details of redemption of preference shares indicating the manner of redemption (whether out of profits or out of fresh issue) and debentures.2. Details of any letter or comments regarding payment/non-payment of interest, principal on due dates, or any other matter concerning the security and /or the assets along with its comments thereon, if any;3. Delay in payment of interest / principal amount for a period of more than three months from the due date or default in payment of interest / principal;4. Special right/interest/privileges attached to the instrument and changes thereof;5. Charge/security, if any, created over the assets;6. Coupon/interest offered, schedule of payment of coupon/interest and principal;7. Tenure of the instrument - date of allotment and date of maturity;8. Whether proposed to be listed? If yes, name of the stock exchange(s);The response of the Company is awaited.25 May · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone Reconciliation of Equity not submitted -2. Consolidated Reconciliation of Equity not submitted The response of the Company is awaited.
Nov 2017
25 Nov · Legal
The exchange asked on 24 Nov 2017
May 2017
26 May · Legal
22 May · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 19-May-2017, regarding "Camlin Fine Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 19, 2017.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.